Dysphagia Affecting Quality of Life in Cerebellar Ataxia-a Large Survey.


Journal

Cerebellum (London, England)
ISSN: 1473-4230
Titre abrégé: Cerebellum
Pays: United States
ID NLM: 101089443

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 15 3 2020
medline: 16 3 2021
entrez: 15 3 2020
Statut: ppublish

Résumé

Dysphagia is a common symptom in neurodegenerative disorders and is generally associated with increased mortality. In the clinical care setting of ataxia patients, no systematical and standardized assessment of dysphagia is employed. Its impact on patients' health-related quality of life is not well understood. To assess the impact of dysphagia in ataxia patients on diet, body weight, and health-related quality of life. We conducted a large survey using self-reported questionnaires for swallowing-related quality of life (Swal-QOL) and a food frequency list in combination with retrospective clinical data of 119 patients with cerebellar ataxia treated in the neurological outpatient clinic of a large German university hospital. Seventeen percent of ataxia patients suffered from dysphagia based on the Swal-QOL score. Less than 1% of all patients reported dysphagia as one of their most disabling symptoms. Dysphagia was associated with unintentional weight loss (p = 0.02) and reduced health-related quality of life (p = 0.01) but did not affect individual nutritional habits (p > 0.05; Chi-squared test). Dysphagia is a relevant symptom in cerebellar ataxia. A systematic screening for dysphagia in patients with cerebellar ataxia would be desirable to enable early diagnosis and treatment.

Identifiants

pubmed: 32170655
doi: 10.1007/s12311-020-01122-w
pii: 10.1007/s12311-020-01122-w
pmc: PMC7198478
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-445

Références

Age Ageing. 2012 May;41(3):376-81
pubmed: 22311895
Mov Disord. 2008 Nov 15;23(15):2232-8
pubmed: 18759344
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Mov Disord. 2010 Apr 15;25(5):587-95
pubmed: 20175183
Neuropathol Appl Neurobiol. 2006 Dec;32(6):635-49
pubmed: 17083478
Dysphagia. 1998 Summer;13(3):151-5
pubmed: 9633155
Qual Life Res. 2013 Aug;22(6):1231-8
pubmed: 23001492
Dysphagia. 2017 Oct;32(5):626-635
pubmed: 28474131
Dysphagia. 2002 Spring;17(2):97-114
pubmed: 11956835
Dysphagia. 2015 Feb;30(1):27-46
pubmed: 25280814
Dysphagia. 2014 Oct;29(5):578-82
pubmed: 24952632
Br Med J (Clin Res Ed). 1987 Oct 31;295(6606):1137-8
pubmed: 3120912
J Neurol. 2006 Jul;253(7):875-81
pubmed: 16619126
Clin Geriatr Med. 1991 May;7(2):215-30
pubmed: 1855155
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Eur J Neurol. 2014 Apr;21(4):607-15
pubmed: 24765663
Dysphagia. 2000 Summer;15(3):122-33
pubmed: 10839824
PLoS One. 2015 May 04;10(5):e0124541
pubmed: 25938478
Arch Neurol. 2001 Jun;58(6):899-904
pubmed: 11405804
Cochrane Database Syst Rev. 2015 Nov 13;(11):CD010169
pubmed: 26564018
Arch Neurol. 1989 Oct;46(10):1121-3
pubmed: 2803071
Eur Neurol. 2015;74(1-2):49-53
pubmed: 26183666
Z Ernahrungswiss. 1998 Sep;37(3):234-41
pubmed: 9800314
J Pediatr. 2000 Feb;136(2):225-31
pubmed: 10657830
J Hum Genet. 2004;49(5):256-64
pubmed: 15362569
Neurology. 1995 Jan;45(1):24-30
pubmed: 7824128
Mov Disord. 2013 Aug;28(9):1200-8
pubmed: 23775899
J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):67-73
pubmed: 9436730
Dysphagia. 2000 Winter;15(1):31-8
pubmed: 10594256
J Neurol. 2014 Feb;261(2):392-9
pubmed: 24371004
Dysphagia. 2013 Sep;28(3):413-8
pubmed: 23515636
JAMA Neurol. 2016 Mar;73(3):321-8
pubmed: 26751506
Arch Neurol. 1991 Aug;48(8):800-4
pubmed: 1832854
Oral Oncol. 2009 Aug;45(8):e67-71
pubmed: 19442567
Pediatr Pulmonol. 2014 Apr;49(4):389-99
pubmed: 23761391

Auteurs

M Rönnefarth (M)

Department of Neurology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

N Hanisch (N)

Department of Neurology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

A U Brandt (AU)

NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

A Mähler (A)

Experimental & Clinical Research Center, Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin, Germany.

M Endres (M)

Department of Neurology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

F Paul (F)

Department of Neurology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Experimental & Clinical Research Center, Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Lindenberger Weg 80, 13125, Berlin, Germany.

Sarah Doss (S)

Department of Neurology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany. sarahjmdoss@gmail.com.
Movement Disorders Section, Department of Neurological Sciences, University of Nebraska Medical Center, 4242 Farnam Street, 68131, Omaha, NE, USA. sarahjmdoss@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH